Expression and mutation analysis of genes that encode the Myc antagonists Mad1, Mxi1 and Rox in acute leukaemia

References

• Henriksson M, Luscher B. Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv Cancer Res 1996; 68: 109–182
   PubMed Web of Science ®Google Scholar
• Blackwood E M, Eisenman R N. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 1991; 251: 1211–1217
   PubMed Web of Science ®Google Scholar
• Billin A N, Eilers A L, Queva C, Ayer D E. Mlx, a novel Max-like BHLHZip protein that interacts with the Max network of transcription factors. J Biol Chem 1999; 274: 36344–36350
   PubMed Web of Science ®Google Scholar
• Gallant P. Myc/Max/Mad in invertebrates: the evolution of the Max network. Curr Top Microbiol Immunol 2006; 302: 235–253
   PubMed Web of Science ®Google Scholar
• Ayer D E, Kretzner L, Eisenman R N. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell 1993; 72: 211–222
   PubMed Web of Science ®Google Scholar
• Zervos A S, Gyuris J, Brent R. Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell 1993; 72: 223–232
   PubMed Web of Science ®Google Scholar
• Hurlin P J, Queva C, Eisenman R N. Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites. Genes Dev 1997; 11: 44–58
   PubMed Web of Science ®Google Scholar
• Edelhoff S, Ayer D E, Zervos A S, Steingrimsson E, Jenkins N A, Copeland N G, et al. Mapping of two genes encoding members of a distinct subfamily of MAX interacting proteins: MAD to human chromosome 2 and mouse chromosome 6, and MXI1 to human chromosome 10 and mouse chromosome 19. Oncogene 1994; 9: 665–668
   PubMed Web of Science ®Google Scholar
• Roy B, Reisman D. Inducible expression of Mad accelerates growth arrest of serum deprived human glioblastoma cells. Cell Biol Int 1995; 19: 307–313
   PubMed Web of Science ®Google Scholar
• Chen J, Willingham T, Margraf L R, Schreiber-Agus N, DePinho R A, Nisen P D. Effects of the MYC oncogene antagonist, MAD, on proliferation, cell cycling and the malignant phenotype of human brain tumour cells. Nat Med 1995; 1: 638–643
   PubMed Web of Science ®Google Scholar
• Prochownik E V, Eagle Grove L, Deubler D, Zhu X L, Stephenson R A, Rohr L R, et al. Commonly occurring loss and mutation of the MXI1 gene in prostate cancer. Genes Chromosomes Cancer 1998; 22: 295–304
   PubMed Web of Science ®Google Scholar
• Li X J, Wang D Y, Zhu Y, Guo R J, Wang X D, Lubomir K, et al. Mxi1 mutations in human neurofibrosarcomas. Jpn J Cancer Res 1999; 90: 740–746
   PubMedGoogle Scholar
• Sommer A, Waha A, Tonn J, Sorensen N, Hurlin P J, Eisenman R N, et al. Analysis of the Max-binding protein MNT in human medulloblastomas. Int J Cancer 1999; 82: 810–816
   PubMed Web of Science ®Google Scholar
• Nigro C L, Venesio T, Reymond A, Meroni G, Alberici P, Cainarca S, et al. The human ROX gene: genomic structure and mutation analysis in human breast tumors. Genomics 1998; 49: 275–282
   PubMed Web of Science ®Google Scholar
• Takahashi T, Konishi H, Kozaki K, Osada H, Saji S, Takahashi T, et al. Molecular analysis of a Myc antagonist, ROX/Mnt, at 17p13.3 in human lung cancers. Jpn J Cancer Res 1998; 89: 347–351
   PubMedGoogle Scholar
• Ayer D E, Lawrence Q A, Eisenman R N. Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. Cell 1995; 80: 767–776
   PubMed Web of Science ®Google Scholar
• Sommer A, Hilfenhaus S, Menkel A, Kremmer E, Seiser C, Loidl P, et al. Cell growth inhibition by the Mad/Max complex through recruitment of histone deacetylase activity. Curr Biol 1997; 7: 357–365
   PubMed Web of Science ®Google Scholar
• Koskinen P J, Ayer D E, Eisenman R N. Repression of Myc-Ras cotransformation by Mad is mediated by multiple protein – protein interactions. Cell Growth Differ 1995; 6: 623–629
   PubMedGoogle Scholar
• Roussel M F, Ashmun R A, Sherr C J, Eisenman R N, Ayer D E. Inhibition of cell proliferation by the Mad1 transcriptional repressor. Mol Cell Biol 1996; 16: 2796–2801
   PubMed Web of Science ®Google Scholar
• Eilers A L, Billin A N, Liu J, Ayer D E. A 13-amino acid amphipathic alpha-helix is required for the functional interaction between the transcriptional repressor Mad1 and mSin3A. J Biol Chem 1999; 274: 32750–32756
   PubMed Web of Science ®Google Scholar
• Hara F, Suzuki T, Saito M, Hikino T, Fukushima T, Oyama T, et al. Non-isotopic single strand conformation polymorphism (PCR-SSCP) with subsequent direct sequencing after silver staining. Pathol Int 1994; 44: 815–816
   PubMed Web of Science ®Google Scholar
• Foley K P, Eisenman R N. Two MAD tails: what the recent knockouts of Mad1 and Mxi1 tell us about the MYC/MAX/MAD network. Biochim Biophys Acta 1999; 1423: M37–M47
   PubMed Web of Science ®Google Scholar
• Kawamata N, Park D, Wilczynski S, Yokota J, Koeffler H P. Point mutations of the Mxil gene are rare in prostate cancers. Prostate 1996; 29: 191–193
   PubMed Web of Science ®Google Scholar
• Bartsch D, Peiffer S L, Kaleem Z, Wells S A, Jr, Goodfellow P J. Mxi1 tumor suppressor gene is not mutated in primary pancreatic adenocarcinoma. Cancer Lett 1996; 102: 73–76
   PubMed Web of Science ®Google Scholar
• Wechsler D S, Shelly C A, Petroff C A, Dang C V. MXI1, a putative tumor suppressor gene, suppresses growth of human glioblastoma cells. Cancer Res 1997; 57: 4905–4912
   PubMed Web of Science ®Google Scholar
• Ferre-D'Amare A R, Prendergast G C, Ziff E B, Burley S K. Recognition by Max of its cognate DNA through a dimeric b/HLH/Z domain. Nature 1993; 363: 38–45
   PubMed Web of Science ®Google Scholar
• Schreiber-Agus N, Meng Y, Hoang T, Hou H, Jr, Chen K, Greenberg R, et al. Role of Mxi1 in aging organ systems and the regulation of normal and neoplastic growth. Nature 1998; 393: 483–487
   PubMed Web of Science ®Google Scholar
• Magrath I. The pathogenesis of Burkitt's lymphoma. Adv Cancer Res 1990; 55: 133–270
   PubMedGoogle Scholar
• Magrath I. The pathogenesis of Burkitt's lymphoma. Adv Cancer Res 1990; 55: 133–270
   PubMedGoogle Scholar